share_log

Warburg Pincus and Lendlease Complete Life Sciences Real Estate JV

Warburg Pincus and Lendlease Complete Life Sciences Real Estate JV

華平置業和臨時升利完成了生命科學房地產業合資。
Singapore Business Review ·  07/31 22:31

Each partner will contribute 50% of the co-investment capital over the next few years.

在未來幾年內,每個合作伙伴都將貢獻50%的共投資本。

Global growth investor Warburg Pincus and Australian real estate group Lendlease have announced the final closing of a new joint venture focused on life sciences real estate.

全球成長投資公司華平投資和澳大利亞房地產集團連德房產宣佈成立一個新的聯合創業公司,專注於生命科學房地產。

Each partner will contribute 50% of the co-investment capital over the next few years, aiming to establish a multi-billion-dollar platform through attracting third-party investors and additional capital.

雙方將在未來幾年投資資本的50%,旨在通過吸引第三方投資者和額外資本,建立一個涉及數十億美元的平台。

The newly formed platform, headquartered in Singapore, will concentrate on investing, acquiring, developing, constructing, managing, and operating real estate projects within the rapidly expanding life sciences and R&D sectors across Asia Pacific.

新成立的總部位於新加坡的平台將專注於投資、收購、開發、施工、管理和運營亞洲太平洋地區快速擴張的生命科學和研發領域的房地產項目。

The joint venture will leverage the extensive sector expertise and market experience of both Warburg Pincus and Lendlease. It is designed to become a leading force in the life sciences and R&D real estate markets in the region.

這個聯合創業公司將發揮華平投資和連德房產在這一領域的豐富專業知識和市場經驗。該公司旨在成爲該地區生命科學和研發房地產市場的主要力量。

The platform is initially seeded with two of Lendlease's existing businesses, including a high-barrier life sciences project construction management business and a specialised investment management business. Its first investment vehicle, LINO, currently holds the Leaf Minatomirai, a 24,000 square meter R&D workplace in Yokohama, which has recently undergone an asset enhancement initiative.

該平台最初採用連德房產的兩項現有業務爲種子企業,其中包括一個高門檻的生命科學項目施工管理業務和一個專門的投資管理業務。其第一個投資車輛LINO目前持有位於橫濱的24,000平方米的R&D辦公場所Leaf Minatomirai,該場所最近進行了資產增值計劃。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論